EX-25.2
Published on February 11, 2011
Exhibit 25.2
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM T-1
STATEMENT OF ELIGIBILITY
UNDER THE TRUST INDENTURE ACT OF 1939 OF A
CORPORATION DESIGNATED TO ACT AS TRUSTEE
UNDER THE TRUST INDENTURE ACT OF 1939 OF A
CORPORATION DESIGNATED TO ACT AS TRUSTEE
CHECK IF AN APPLICATION TO DETERMINE
ELIGIBILITY OF A TRUSTEE PURSUANT TO
SECTION 305(b)(2) o
ELIGIBILITY OF A TRUSTEE PURSUANT TO
SECTION 305(b)(2) o
THE BANK OF NEW YORK MELLON
TRUST COMPANY, N.A.
TRUST COMPANY, N.A.
(Exact name of trustee as specified in its charter)
(Jurisdiction of incorporation if not a U.S. national bank) |
95-3571558 (I.R.S. employer identification no.) |
|
700 South Flower Street Suite 500 Los Angeles, California (Address of principal executive offices) |
90017 (Zip code) |
NOVELIS INC.
(Exact name of obligor as specified in its charter)
Canada (State or other jurisdiction of incorporation or organization) |
98-0442987 (I.R.S. employer identification no.) |
Novelis Corporation
(Exact name of obligor as specified in its charter)
Texas (State or other jurisdiction of incorporation or organization) |
41-2098321 (I.R.S. employer identification no.) |
Eurofoil Inc. (USA)
(Exact name of obligor as specified in its charter)
New York (State or other jurisdiction of incorporation or organization) |
13-3783544 (I.R.S. employer identification no.) |
Novelis PAE Corporation
(Exact name of obligor as specified in its charter)
Delaware (State or other jurisdiction of incorporation or organization) |
36-4266108 (I.R.S. employer identification no.) |
Aluminum Upstream Holdings LLC
(Exact name of obligor as specified in its charter)
Delaware (State or other jurisdiction of incorporation or organization) |
20-5137700 (I.R.S. employer identification no.) |
Novelis Brand LLC
(Exact name of obligor as specified in its charter)
Delaware (State or other jurisdiction of incorporation or organization) |
26-0442201 (I.R.S. employer identification no.) |
-2-
Novelis South America Holdings LLC
(Exact name of obligor as specified in its charter)
Delaware (State or other jurisdiction of incorporation or organization) |
20-5137684 (I.R.S. employer identification no.) |
Novelis North America Holdings Inc.
(Exact name of obligor as specified in its charter)
Delaware (State or other jurisdiction of incorporation or organization) |
90-0636088 (I.R.S. employer identification no.) |
Novelis Acquisitions LLC
(Exact name of obligor as specified in its charter)
Delaware (State or other jurisdiction of incorporation or organization) |
27-4077666 (I.R.S. employer identification no.) |
Novelis Cast House Technology Ltd.
(Exact name of obligor as specified in its charter)
Canada (State or other jurisdiction of incorporation or organization) |
Not applicable (I.R.S. employer identification no.) |
Novelis No. 1 Limited Partnership
(Exact name of obligor as specified in its charter)
Canada (State or other jurisdiction of incorporation or organization) |
Not applicable (I.R.S. employer identification no.) |
-3-
4260848 Canada Inc.
(Exact name of obligor as specified in its charter)
Canada (State or other jurisdiction of incorporation or organization) |
Not applicable (I.R.S. employer identification no.) |
4260856 Canada Inc.
(Exact name of obligor as specified in its charter)
Canada (State or other jurisdiction of incorporation or organization) |
Not applicable (I.R.S. employer identification no.) |
Novelis Europe Holdings Ltd.
(Exact name of obligor as specified in its charter)
United Kingdom (State or other jurisdiction of incorporation or organization) |
Not applicable (I.R.S. employer identification no.) |
Novelis UK Ltd.
(Exact name of obligor as specified in its charter)
United Kingdom (State or other jurisdiction of incorporation or organization) |
Not applicable (I.R.S. employer identification no.) |
Novelis Services Limited
(Exact name of obligor as specified in its charter)
United Kingdom (State or other jurisdiction of incorporation or organization) |
Not applicable (I.R.S. employer identification no.) |
-4-
Novelis do Brasil Ltda.
(Exact name of obligor as specified in its charter)
Brazil (State or other jurisdiction of incorporation or organization) |
Not applicable (I.R.S. employer identification no.) |
Novelis AG
(Exact name of obligor as specified in its charter)
Switzerland (State or other jurisdiction of incorporation or organization) |
Not applicable (I.R.S. employer identification no.) |
Novelis Switzerland S.A.
(Exact name of obligor as specified in its charter)
Switzerland (State or other jurisdiction of incorporation or organization) |
Not applicable (I.R.S. employer identification no.) |
Novelis Technology AG
(Exact name of obligor as specified in its charter)
Switzerland (State or other jurisdiction of incorporation or organization) |
Not applicable (I.R.S. employer identification no.) |
Novelis Aluminum Holding Company
(Exact name of obligor as specified in its charter)
Ireland (State or other jurisdiction of incorporation or organization) |
Not applicable (I.R.S. employer identification no.) |
-5-
Novelis Deutschland GmbH
(Exact name of obligor as specified in its charter)
Germany (State or other jurisdiction of incorporation or organization) |
Not applicable (I.R.S. employer identification no.) |
Novelis Luxembourg S.A.
(Exact name of obligor as specified in its charter)
Luxembourg (State or other jurisdiction of incorporation or organization) |
Not applicable (I.R.S. employer identification no.) |
Novelis PAE S.A.S.
(Exact name of obligor as specified in its charter)
France (State or other jurisdiction of incorporation or organization) |
Not applicable (I.R.S. employer identification no.) |
Novelis Madeira, Unipessoal, Lda
(Exact name of obligor as specified in its charter)
Portugal (State or other jurisdiction of incorporation or organization) |
Not applicable (I.R.S. employer identification no.) |
3560 Lenox Road, Suite 2000 Atlanta, Georgia (Address of principal executive offices) |
30326 (Zip code) |
8.75% Senior Notes due 2020
and Guarantees of 8.75% Senior Notes due 2020
(Title of the indenture securities)
and Guarantees of 8.75% Senior Notes due 2020
(Title of the indenture securities)
-6-
1. | General information. Furnish the following information as to the trustee: |
(a) | Name and address of each examining or supervising authority to which it is subject. |
Name | Address | |
Comptroller of the Currency United States Department of the Treasury
|
Washington, DC 20219 | |
Federal Reserve Bank
|
San Francisco, CA 94105 | |
Federal Deposit Insurance Corporation
|
Washington, DC 20429 |
(b) | Whether it is authorized to exercise corporate trust powers. |
Yes. | ||
2. | Affiliations with Obligor. | |
If the obligor is an affiliate of the trustee, describe each such affiliation. | ||
None. | ||
16. | List of Exhibits. | |
Exhibits identified in parentheses below, on file with the Commission, are incorporated herein by reference as an exhibit hereto, pursuant to Rule 7a-29 under the Trust Indenture Act of 1939 (the Act) and 17 C.F.R. 229.10(d). |
1. | A copy of the articles of association of The Bank of New York Mellon Trust Company, N.A., formerly known as The Bank of New York Trust Company, N.A. (Exhibit 1 to Form T-1 filed with Registration Statement No. 333-121948 and Exhibit 1 to Form T-1 filed with Registration Statement No. 333-152875). | ||
2. | A copy of certificate of authority of the trustee to commence business. (Exhibit 2 to Form T-1 filed with Registration Statement No. 333-121948). | ||
3. | A copy of the authorization of the trustee to exercise corporate trust powers (Exhibit 3 to Form T-1 filed with Registration Statement No. 333-152875). |
-7-
4. | A copy of the existing by-laws of the trustee (Exhibit 4 to Form T-1 filed with Registration Statement No. 333-162713). |
6. | The consent of the trustee required by Section 321(b) of the Act (Exhibit 6 to Form T-1 filed with Registration Statement No. 333-152875). |
7. | A copy of the latest report of condition of the Trustee published pursuant to law or to the requirements of its supervising or examining authority. |
-8-
SIGNATURE
Pursuant to the requirements of the Act, the trustee, The Bank of New York Mellon Trust
Company, N.A., a banking association organized and existing under the laws of the United States of
America, has duly caused this statement of eligibility to be signed on its behalf by the
undersigned, thereunto duly authorized, all in the City of Atlanta, and State of Georgia, on the
10th day of February, 2011.
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. |
||||
By: | /S/ Reda Sabaliauskaite | |||
Name: | Reda Sabaliauskaite | |||
Title: | Senior Associate | |||
-9-
EXHIBIT 7
Consolidated Report of Condition of
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
of 700 South Flower Street, Suite 200, Los Angeles, CA 90017
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
of 700 South Flower Street, Suite 200, Los Angeles, CA 90017
At the close of business September 30, 2010, published in accordance with Federal regulatory
authority instructions.
Dollar Amounts | ||||
in Thousands | ||||
ASSETS |
||||
Cash and balances due from
depository institutions: |
||||
Noninterest-bearing balances
and currency and coin |
1,595 | |||
Interest-bearing balances |
276 | |||
Securities: |
||||
Held-to-maturity securities |
7 | |||
Available-for-sale securities |
703,294 | |||
Federal funds sold and securities
purchased under agreements to resell: |
||||
Federal funds sold |
76,500 | |||
Securities purchased under agreements to resell |
0 | |||
Loans and lease financing receivables: |
||||
Loans and leases held for sale |
0 | |||
Loans and leases,
net of unearned income |
0 | |||
LESS: Allowance for loan and
lease losses |
0 | |||
Loans and leases, net of unearned
income and allowance |
0 | |||
Trading assets |
0 | |||
Premises and fixed assets (including
capitalized leases) |
9,503 | |||
Other real estate owned |
0 | |||
Investments in unconsolidated
subsidiaries and associated
companies |
0 | |||
Direct and indirect investments in real estate ventures |
0 | |||
Intangible assets: |
||||
Goodwill |
856,313 | |||
Other intangible assets |
223,370 | |||
Other assets |
156,663 | |||
Total assets |
$ | 2,027,521 | ||
1
Dollar Amounts | ||||
in Thousands | ||||
LIABILITIES |
||||
Deposits: |
||||
In domestic offices |
500 | |||
Noninterest-bearing |
500 | |||
Interest-bearing |
0 | |||
Not applicable |
||||
Federal funds purchased and securities
sold under agreements to repurchase: |
||||
Federal funds purchased |
0 | |||
Securities sold under agreements to repurchase |
0 | |||
Trading liabilities |
0 | |||
Other borrowed money: |
||||
(includes mortgage indebtedness
and obligations under capitalized
leases) |
268,691 | |||
Not applicable |
||||
Not applicable |
||||
Subordinated notes and debentures |
0 | |||
Other liabilities |
220,845 | |||
Total liabilities |
490,036 | |||
Not applicable |
||||
EQUITY CAPITAL |
||||
Perpetual preferred stock and related surplus |
0 | |||
Common stock |
1,000 | |||
Surplus (exclude all surplus related to preferred stock) |
1,121,520 | |||
Not available |
||||
Retained earnings |
412,405 | |||
Accumulated other comprehensive income |
2,560 | |||
Other equity capital components |
0 | |||
Not available |
||||
Total bank equity capital |
1,537,485 | |||
Noncontrolling (minority) interests in consolidated subsidiaries |
0 | |||
Total equity capital |
1,537,485 | |||
Total liabilities and equity capital |
2,027,521 | |||
I, Karen Bayz, Managing Director of the above-named bank do hereby declare that the Reports of
Condition and Income (including the supporting schedules) for this report date have been prepared
in conformance with the instructions issued by the appropriate Federal regulatory authority and are
true to the best of my knowledge and belief.
Karen Bayz | ) Managing Director |
We, the undersigned directors (trustees), attest to the correctness of the Report of Condition
(including the supporting schedules) for this report date and declare that it has been examined by
us and to the best of our knowledge and belief has been prepared in conformance with the
instructions issued by the appropriate Federal regulatory authority and is true and correct.
Troy Kilpatrick, President | ) | |
Frank P. Sulzberger, MD | ) Directors (Trustees) | |
William D. Lindelof, MD | ) |
2